CompletedNCT02102802
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD
Observational studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Mt. Pleasant, United StatesSee all locations and recruitment
- Activities
- Medication exposure observed; not assigned by the study · Behavioural activities described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateJanuary 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Resilient Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02102802
- Official title
Show the full official title
Exploring Mechanisms of Action of ±3,4-methylenedioxymethamphetamine (MDMA)- Assisted Psychotherapy for Posttraumatic Stress Disorder (PTSD)
Recruitment & locations
CompletedMt. Pleasant
Questions about this study
Who is behind this study?
The study sponsor is Resilient Pharmaceuticals.
Did this study involve medication?
Yes. The study involved medication, including Midomafetamine.
Who was this study for?
Listed age limits: from 18 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me